Compare
Tactile Systems Technology Inc vs Angiodynamics Inc vs SkinHealth Systems Inc. vs Mimedx Group, Inc.
| Latest fiscal year | Tactile Systems Technology Inc TCMD | Angiodynamics Inc ANGO | SkinHealth Systems Inc. SKIN | Mimedx Group, Inc. MDXG |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2026-05-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $329.52M | $320.17M | $300.79M | $418.63M |
| Revenue growth (YoY) | +12.5% | +9.5% | -10.0% | +20.0% |
| Gross margin | 75.9% | 54.6% | 65.3% | 82.6% |
| Operating margin | 8.9% | -12.5% | -6.9% | 15.3% |
| Net margin | 5.8% | -11.5% | -3.2% | 11.6% |
| Net income | $19.09M | -$36.74M | -$9.52M | $48.58M |
| EPS (Diluted) | $0.82 | -$0.88 | -$0.16 | $0.32 |
| Operating cash flow | $42.81M | $3.09M | $37.48M | $74.00M |
| Free cash flow | $40.43M | $508.0K | $37.18M | n/a |
| Cash & equivalents | $83.45M | $53.86M | n/a | $166.12M |
| Total assets | $273.94M | $267.16M | $499.80M | $342.65M |
| Total liabilities | $55.04M | $96.34M | $438.75M | $86.11M |
| Shareholders' equity | $218.90M | $170.82M | $61.06M | $256.55M |
| Return on year-end equity | 8.7% | -21.5% | -15.6% | 18.9% |
| Shares outstanding | 22.44M | 41.70M | 127.52M | 148.09M |
Revenue, most recent five fiscal years
| Fiscal year | Tactile Systems Technology Inc | Angiodynamics Inc | SkinHealth Systems Inc. | Mimedx Group, Inc. |
|---|---|---|---|---|
| Latest | $329.52M Ended 2025-12-31 | $320.17M Ended 2026-05-31 | $300.79M Ended 2025-12-31 | $418.63M Ended 2025-12-31 |
| 1 year earlier | $292.98M Ended 2024-12-31 | $292.50M Ended 2025-05-31 | $334.29M Ended 2024-12-31 | $348.88M Ended 2024-12-31 |
| 2 years earlier | $274.42M Ended 2023-12-31 | $303.91M Ended 2024-05-31 | $397.99M Ended 2023-12-31 | $321.48M Ended 2023-12-31 |
| 3 years earlier | $246.78M Ended 2022-12-31 | $338.75M Ended 2023-05-31 | $365.88M Ended 2022-12-31 | $267.84M Ended 2022-12-31 |
| 4 years earlier | $208.06M Ended 2021-12-31 | $316.22M Ended 2022-05-31 | $260.09M Ended 2021-12-31 | $242.02M Ended 2021-12-31 |